Search Results for: THCA

Cannabis Nurses Network Conference 2020 With Focus On How Cannabis Has Caused A Revolution In Healthcare

Virtual Educational Session and Panels Devoted on New and Promising Cannabis-based Therapeutics

Conference expected to be in person in 2021 with Ticket in 2020 to include both Events

CALIFORNIA: Noted medical cannabis experts and health professionals will be leading educational panels and continued education programs at this year’s Cannabis Nurses Network Conference (CNNC), the annual professional development and education conference designed exclusively for Registered Nurses and wellness professionals to advance their understanding of cannabis medicine, the endocannabinoid system, and practical applications in day-to-day patient care & practice.

This year’s conference will be held virtually on September 3rd and 4th. This year’s ticket includes an in-person ticket for 2021’s CNNC conference, expected to be held in San Diego once it is safe to do so.

CNNC 2020 is an advanced, unique, and empowering 2-day education experience; the program is designed for nurses, healthcare and licensed wellness professionals who are serious about advancing their expertise in cannabis medicine. According to Cannabis Nurses Network, the speakers, education content and programming schedule for September will continue as planned, and for the in-person experience will be built upon the virtual event with even more advanced education, and additional speakers.

“We will take the “Revolution in Healthcare” theme of our conference very seriously – so we are taking this opportunity to continue with our conference, by innovating on the CNNC experience. We have moved the conference into a virtual space for the September 3rd-4th 2020, with special experiences designed to take advantage of online technology. Once large events have been given the “all clear” by the State of California, we will be rescheduling our in-person event for an appropriate time in 2021,” said CNN Founding Member, Heather Manus, RN.

Tickets to CNNC 2020 will get attendees admission to TWO full scale cannabis education conferences for medical professionals. According to CNN management, this is a great opportunity for new cannabis nurses to participate in the privacy of their own home, making connections and new friends they can join at the in-person event when it is rescheduled.

Nurse Heather Manus is founder of the Cannabis Nurses Network

TOPICS FOR 2020 VIRTUAL CNNC: ESSENTIAL EDUCATION AND EXPERT PANEL SESSIONS

CNNC 2020 offers two full days delivering accredited continuing nurse education credits (CEU) in cannabis medicine education. Healthcare professionals are encouraged to register to learn about cannabis science, research, and clinical applications related to the human endocannabinoid system and cannabinoid therapeutics from world-class experts.

This year’s topics include:

  • Cannabis and Cancer Care – Can Cannabis offer Quality of Life
  • The Emergence of Cannabis Nurses
  • New and Promising Cannabis Therapeutics
  • Overcoming Roadblocks to Effective Care
  • Pharmaceutical considerations for Nurses
  • Supporting Patient Empowerment
  • Healing with a Tender Touch
  • Nurturing Nursing Partnerships
  • Advancing Nursing Practice
  • Elevating Sports Medicine
  • New Approach to Elder Care
  • Lessons from Plant Messengers
  • Hemp Healing: Planet, Progress and People
  • Political Nature of Healthcare and Research

“Patients are using cannabis legally, with or without medical oversight. Nurses are being encouraged by the National Council State Boards of Nursing (NCSBN) to seek and gain knowledge regarding Cannabis Patient Care. I believe we are witnessing a revolution in healthcare, and Nurses are among those at the forefront,” adds Nurse Manus. For more information on purchasing tickers for both the 2020 and 2021 events, please log to Cannabis Nurses Network.

Ilera Healthcare To Host Free Screening Of Award-Winning Veteran MMJ Documentary ‘Unprescribed’

November 15th Screening In Plymouth Meeting, PA

PENNSYLVANIA: Pennsylvania medical marijuana company and dispensary, Ilera Healthcare, will host a free screening of Unprescribed, followed by a panel discussion, on Friday, November 15th at 6:30 pm at Greater Plymouth Community Center in Plymouth Meeting.  The documentary film highlights medical marijuana (MMJ) as an alternative to the cocktail of drugs prescribed by military doctors for veterans struggling with PTSD, anxiety and other service-related health issues.

For many of our returning veterans, the battle continues out of uniform as they attempt to recover from war-related trauma through a multitude of prescription medicines.  In his first feature-length motion picture, producer, director, and Air Force veteran Steve Ellmore presents us with stories from fellow veterans, spouses, and family members on coping with war-related injuries and the loss of loved ones due to suicide. After returning from combat these veterans are prescribed what many refer to as the ‘combat cocktail’ or ‘zombie dope,’ leading many to believe that suicide is a possible solution to their pain.  The film takes a closer look at medical marijuana, which could provide a safer alternative for many returning soldiers. Unprescribed has recently won the Grand Jury Prize for Best Documentary Film at the Los Angeles Motion Picture Festival, Best Feature Documentary at the 2019 Cannabis Culture Film Festival, and was theBe the Change Winner at the Colorado International Activism Film Festival.  Unprescribed is also an official selection at the 2019 London Cannabis Film Festival, San Francisco Veterans Film Festival, and Honor Film Festival.   

At the conclusion of the screening, Ellmore will join Ilera’s Chief Scientific Officer Dr. Oludare Odumosu ,  clinical psychiatrist Dr. Lynn Bornfriend, Ron Milward of Balanced Veterans, Bill Ferguson of Veteran Cannabis Coalition, and veteran advocate and social media influencer Derek Carter on a panel to further explore MMJ as it pertains to easing the physical and mental pain of those returning from the armed forces. 

Also featured on the panel will be Christian Ryan, an MMJ advocate and US Army combat veteran, who served in Iraq. Besides advocating for veterans to have access to MMJ through his founding of the Veterans Medical Marijuana Advisory Council (V.M.M.A.C.), Christian, who is employed at Ilera, inspired the development of the company’s new  FREEDOM medical cannabis formulation.  

Greater Plymouth Community Center is located at 2910 Jolly Road in Plymouth Meeting, Pennsylvania.  To reserve free tickets to the Unprescribed screening and panel Q&A please visit.  

TerrAscend Completes Acquisition Of Ilera Healthcare

Expands licensed cannabis footprint to four U.S. states, in addition to global reach into Canada and Europe

CANADA: TerrAscend, the first and only global cannabis company licensed for sales in Canada, the US, and the EU, announced it has closed on its previously announced acquisition of Pennsylvania-based Ilera Healthcare, one of five permitted vertically-integrated cannabis cultivator, processor, and dispensary operators in the state. With the completion of this transaction, TerrAscend’s licensed cannabis footprint expands to four U.S. states, in addition to its global reach into Canada and Europe.

“As one of only 5 holders of Super Licenses in a limited license state with approximately 13 million people, Ilera is an ideal partner for TerrAscend to enter the Pennsylvania market with,” said Matthew Johnson, President of TerrAscend Corp., and TerrAscend USA, Inc. “We welcome Greg and the rest of the Ilera team to the TerrAscend family, and we look forward to partnering together as we continue to build the leading North American Operator (NAO) in the cannabis space.”

Greg Rochlin, CEO of Ilera, said, “By combining forces with TerrAscend, we see clear opportunities ahead for our stakeholders, employees and patients. We look forward to accelerating the growth of Ilera’s brands and formulations by leveraging TerrAscend’s platform in other markets. I can’t wait to introduce our wholesale customers and patients to the California-born Valhalla and State Flower brands, as well as Haven Street, a leading premium Canadian brand.”

Osagie Imasogie, Chairman of the Board for Ilera Healthcare added, “We know that Ilera’s original mission to deliver consistent premium cannabis medicines to patients throughout Pennsylvania will be carried on by TerrAscend, who shares our culture, and above all, our commitment to the highest standards of quality and patient service.”

Ilera currently operates a retail dispensary in Plymouth Meeting, PA, with plans to open two additional dispensary sites in the Philadelphia area within the next six months. The operations include a 67,000 square foot site for cultivation and processing in Waterfall, PA with planned expansion to over 120,000 square feet in 2020. In addition to selling its products in its own dispensary, Ilera distributes its dried flower, concentrates, tinctures, and topicals to over 60 dispensaries throughout Pennsylvania. Ilera’s current revenue run-rate is over US$43 million1, up from total sales in 2018 of less than US$8 million1. For more information about Ilera Healthcare.

The Pennsylvania medical marijuana program has more than 180,000 registered patients and 20,000 registered caregivers as of August 2019, and covers 23 qualifying medical conditions including anxiety disorders, cancer, and opioid use disorder3. Those seeking more information about Pennsylvania’s medical marijuana program can visit www.medicalmarijuana.pa.gov.

Transaction Details: The transaction closed at previously disclosed terms.

TerrAscend reiterates its current 2019 guidance of revenue in excess of C$141 million, which includes contribution from the Ilera transaction and pending disclosed transactions, as previously announced on August 22, 2019.

How Legalized Marijuana is Changing The Healthcare Industry

by Trevor McDonald

Medical marijuana continues to be a hot-button issue, and we can expect that to continue until it’s legalized in all 50 states. But as the debate heats up and more states approve medical marijuana, we can look to the early adopters to find out what’s working.

Here are a few ways legalized marijuana is changing the healthcare industry.

Fewer opioid overdose deaths

In states that have legalized marijuana, we’re seeing fewer deaths from opioid overdose. In fact, a 2014 Journal of the American Medical Association study found that states with medical marijuana programs have a 25 percent lower opioid-related death rate than states that haven’t approved marijuana for medical use.

America’s addiction epidemic is currently claiming an average of 115 lives every day, so this is clearly an issue that is rocking the healthcare in addition to thousands of families. If we can reduce those overdose deaths by 25 percent, that would equate to nearly 29 fewer overdose deaths – every day.

Marijuana is showing promise for chronic pain

Harvard researchers completed a systematic review of the available research and found that almost all patients who took marijuana for chronic pain saw some improvement.

This is likely why we’re seeing fewer opioid prescriptions in states that have legalized marijuana.

For those who understand how both of these medications work, this news should come as no surprise. Opioids and marijuana both work as analgesics, so they block pain signals within the nervous system. THC binds to CB1 and CB2 receptors to block pain signals while opioids bind to opioid receptors.

A Cannabis and Cannabinoid Research study suggests that patients even prefer cannabis over opioids. Researchers found that 81 percent of patients who used opioids believe that adding medical marijuana is more effective than opioids alone.

Fewer prescriptions for anxiety and depression

In states that have legalized medical marijuana, doctors seem to prescribe fewer doses of anxiety and depression medications. A 2016 a Health Affairs study found that Medicare prescriptions for drugs used to treat these conditions dropped. Interestingly, researchers only found a dip in prescriptions for conditions that marijuana can effectively treat. They did not see the same drop in other prescriptions.

It’s important to note that marijuana can exacerbate some mental health conditions, and it can even make anxiety worse for some people. Tetrahydrocannabinol (THC) has also been associated with psychosis in some cases.

Medical marijuana has emerged as an alternative to many prescription medications with dangerous side effects. Because of this, the benefits of using marijuana in these areas far outweighs any risks.

Still, we must remember that medically-approved marijuana is in its infancy. At best, we have about two decades of history to draw from. As more states legalize cannabis, we’ll have a better picture of its full impact on the healthcare system.

 

Author Bio: Trevor is a freelance content writer and a recovering addict & alcoholic who’s been clean and sober for over 5 years. Since his recovery began, he has enjoyed using his talent for words to help spread treatment resources, addiction awareness, and general health knowledge. In his free time, you can find him working with recovering addicts or outside enjoying about any type of fitness activity imaginable.

Tikun Olam and Ilera Healthcare Announce Pennsylvania Partnership

PENNSYLVANIA and NEW YORK:  Tikun Olam, the world leader in cannabis science, and Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser, have finalized a deal to bring Tikun’s world-renowned medical marijuana strains to medical cannabis patients in the Keystone State later this year.

This partnership combines Tikun Olam’s history of peer-reviewed scientific research and unprecedented clinical data collection with Ilera’s expertise in formulating and delivering high-quality pharmaceutical-grade medical cannabis products to Pennsylvanians. Products developed from Tikun Olam’s proprietary strains, including its world-renowned Avidekel high-CBD strain, will be available in vape oils, tinctures and topical formulations.

Tikun Olam has created numerous cannabis strains designed to deliver symptomatic relief for specific conditions in line with the 17 medical conditions approved for medical cannabis use in Pennsylvania, including autism, cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to name a few.
“Tikun Olam has spent years developing our strains through scientific methods,” says Tikun CEO Bernie Sucher. “Finding the ideal partner that shares our focus on quality control and consistency from seed to sale was a top priority for our Pennsylvania launch, and Ilera Healthcare was our top choice.”
Greg Rochlin, CEO of Ilera Healthcare, sees this as a natural partnership. “Ilera is dedicated to producing consistent, high-quality medications with effects that are supported by data, and so is Tikun Olam.”

Skipta And The Fresh Toast Bring Cannabinoid Medicine Information To Healthcare Professionals

PENNSYLVANIA & WASHINGTON: Skipta, a leading social network of specialized online medical communities for verified healthcare professionals, including Oncology Nation, Psychiatrist Connect and Doctor Unite, announced today its partnership with new media company, The Fresh Toast, to provide trusted, reliable information on cannabinoid medicine.

In a first for the cannabis industry, this partnership will provide guidelines and research information for the potential medicinal uses of cannabis to alleviate symptoms from identified diseases and illness.  The Fresh Toast will serve as an exclusive media partner for news and information on cannabinoid medicine as authored by Skipta or its members.

The Fresh Toast, a daily lifestyle and entertainment site with a side of cannabis, launched in October 2016 and is the first cannabis site to have mainstream appeal.  Traffic to TheFreshToast.com has quickly grown, with 25 percent of readers returning for multiple visits per day, according to the company press release.  The Fresh Toast has a large number of female readers with a 43/57 female/male mix.

A key section of The Fresh Toast is the Rx overseen by Tom Green, MD.  As the first site with a continuum of care, the site’s goal is providing knowledge in an understandable and familiar format allowing patients and caregivers to learn about the diseases that could benefit from the use of cannabinoid medicine and their potential treatment options.  The site is investing in expanding health coverage and sharing patient stories to give a full picture of the pluses and minuses.

“There’s certainly demand for high-quality and trustworthy cannabis information.  People want to get it from a publisher they trust,” said Christian Hendricks, a board member of The Fresh Toast and well-known media executive.

“The partnership between The Fresh Toast and Skipta can be a transformational step forward for medical cannabis.  The Fresh Toast is one of the leading voices on all things cannabis and, by forging a relationship with a massive network of healthcare professionals, it will increase information, knowledge, and access to knowledge for those at the forefront of the medical cannabis conversation.  Relationships like this one help fill a government-driven, gaping void in our understanding of medical cannabis and the realities of its practice in American society,” said John Hudak, Ph.D., senior fellow in governance studies at the Brookings Institution and author of Marijuana: A Short History.

“We are proud to work with the Skipta team of medical professionals,” said JJ McKay, founder/publisher of The Fresh Toast.  “With 40 percent of our readership coming from red states, I believe we offer a vehicle to reach the general public.  With proper use, cannabinoid medicine can help tens of millions of people.  With national leaders like Sanjay Gupta and Senator Orrin Hatch endorsing medical cannabis, we are honored to work with Skipta to help improve people’s lives.”

International Collaborative Study Reveals The Neuroprotective Properties of Phytocannabinoid Δ9-THCA

SPAIN:  Advanced medical research conducted at Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) as a collaborative effort between Phytoplant Research SL, VivaCell Biotechnology España SL, and Emerald Health Pharmaceuticals has unveiled the potent neuroprotective ability of Δ9-THCA, a phytocannabinoid produced in Cannabis sativa L. The research paper was accepted and published in the British Journal of Pharmacology.

The findings suggest that Δ9-THCA can potentially protect brain cells from degenerative diseases, such as Huntington’s disease, and could be a viable treatment option for patients suffering from debilitating neurodegenerative diseases such as multiple sclerosis (MS), Alzheimer’s and Parkinson’s disease.

“We demonstrated that Δ9-THCA, the main non psychoactive phytocannabinoid biosynthesized by the Cannabis sativa L. plant, exerts neuroprotective action in its raw form without acting on the endocannabinoid system, but by activating the PPARγ receptors, thereby avoiding the undesired psychotropic effects. This finding will open a new range of cannabinoid neuroprotective applications,” said Dr. Xavier Nadal, Manager, Extraction R&D Department, Phytoplant Research SL.

Δ9-THCA is not only the most abundant non-psychoactive cannabinoid found in marijuana but also an acidic phytocannabinoid. PPARγ is the nuclear receptor for some cannabinoids and PPARγ signalling has a role in neuroinflammation and epilepsy. As a potent PPARγ agonist, this effectual neuroprotectant exhibited neuroprotective and neuroinflammatory activity in an animal model of Huntington’s disease (HD).

 

How Healthcare Professionals Are Getting Involved In The Legal Cannabis Industry

Medical professionals and their approaches to the growing MMJ industry

By Zack M

As the medical marijuana industry continues to grow, so too does the opportunity for innovation. Healthcare professionals in particular are taking part in this boom and have been approaching the legal cannabis industry in a multitude of ways.

Education and Training

Although medical marijuana is legal in certain states, there remains a dearth of licensed healthcare professionals catering to patients wishing to seek treatment via medical cannabis. A study of physicians’ attitudes towards marijuana as conducted by Konrad and Reid concluded that whilst only 19% of respondents believed physicians should recommend medical cannabis to patients, a whopping 92% agreed that education about medical marijuana should be made available to them. As such, several organizations exist that are helping educate medical professionals about how to incorporate MMJ in their practice.

The New York State Medical Marijuana Program for instance offers practitioner education, practitioner registration, patient certification, and the identification of registered practitioners. These facilities allow doctors to recommend medical marijuana to their patients and understand the laws surrounding it with ease. 602 physicians have registered as of June 21, 2016 and many similar organizations and resources for doctors can be found online and nationwide.

Ivy league doctor, Dr. David Casarett has too recognized the lack of medical cannabis education available to not merely physicians, but patients, dispensary owners, and growers. In his book, Stoned: A Doctor’s Case for Medical Marijuana, Casarett makes compelling arguments for medical marijuana’s risks and benefits. He hopes that his book will serve as a guide and that it can address the fact that many of his “physician colleagues are realizing that [medical marijuana] is something they should know about,” adding that “they may decide that they won’t recommend [medical marijuana], but they have to know about it.”

Less conventional than that of doctors’ is the introduction of nurses to the field of medical marijuana.Unlike physicians, nurses do not legally require certification to assist patients wishing to obtain prescriptions for medical marijuana.  Just as there is a lack of physicians working with MMJ patients, even more pronounced is the absence of nurses in this respect.

Patients normally receive most of their advice from doctors and dispensary staff regarding the appropriate cannabinoids, dosage, and delivery methods. Organizations like the American Cannabis Nurses Association (ACNA) have emerged in order to fill this gap. With a mission to “advance excellence in cannabis nursing practice through advocacy, collaboration, research, education, and policy development,” the ACNA stands as a forum and platform for education. Understanding “how and why patients are choosing this treatment” and “how this use effects other medical treatments” can help nurses better connect with their MMJ patients and ensure patients get proper therapy.

Unconventional Approaches

A new service in California called Meadow—which began as a medical marijuana delivery service—ventures outside the box in the name of convenience. It permits doctors to make house calls for medical cannabis related concerns. Services such as these help bridge the gap between potential patients and doctors and make it easier for people to receive accessible treatment.

Dermatologists too are taking advantage of the legal cannabis industry by creating topical skincare products with marijuana as the active ingredient. Some skincare experts claim that when applied topically, marijuana could make skin look younger as well as treat certain skin conditions such as dry and itchy skin.

With all these new developments in an industry only in its infancy, we can be sure to expect a future of healthcare professionals entering the field in a wider range and larger volume of ways.

Patients, Caregivers And Healthcare Providers Travel to Albany To Urge Gov. Cuomo And Senate to Pass Comprehensive Medical Marijuana Legislation

NEW YORK:  On Monday, January 13th, dozens of patients,  families, caregivers and healthcare providers will gather in Albany for a press conference and lobby day to call upon Governor Andrew Cuomo and the State Senate to pass the Compassionate Care Act — A.6357-A (Gottfried) / S.4406-A (Savino) .

The patients are living with cancer, multiple sclerosis, severe seizure disorders, and other serious, debilitating medical conditions, and the families include parents of children who suffer from severe forms of epilepsy, such as Dravet’s syndrome. Travelling from all corners of the State, they will call on the Senate to pass and the Governor to support the Compassionate Care Act – comprehensive legislation that would allow seriously ill New Yorkers access to medical marijuana under the supervision of their healthcare provider. [Read more…]

How I Became A Cannabis Pharmacist & Entrepreneur

By Daniel Asarch

Growing up in the 1980s, I was a child of the D.A.R.E program.  Everyday I would be inundated with this is your brain on drugs commercials as well as other anti-cannabis propaganda.  The stoner stigma and  government scare tactics worked for numerous years, but I finally gave into trying cannabis for the first time in college.  After trying it, I didn’t see what the big fuss about cannabis was as it didn’t do much for me except give me the munchies. As the years went by I used cannabis sporadically for recreational purposes and yet still didn’t have much knowledge about the plant.  Even when I attended pharmacy school in the early 2000s, the only two things I learned was cannabis existed as marijuana and Marinol, a synthetic thc pharmaceutical.

Working as a pharmacist I had patients on Marinol to help stimulate their appetites as they were either burdened with HIV or a form of cancer.   All of my patients preferred cannabis over Marinol.  They complained that Marinol had unpleasant side effects and that it didn’t help much with appetite stimulation.  However, my patients were stuck between a rock and hard place as medical marijuana was allowed but at the same time it couldn’t be legally bought anywhere at the time.  Outside of the need for appetite stimulation, some of my HIV and cancer patients were also on opioids or opioid related medications to help control their chronic pain.

In my 17 years of being a pharmacist, one of the hardest things to watch is people becoming addicted to opioids to help manage their chronic pain.  I probably have dispensed thousands of pain pills to patients.  All of them had legitimate scripts, but I’m also sure there may have been a few scrupulous patients that may have slipped through.  Opioid addiction takes a toll on the   mind and body as well as the patient’s surrounding environment.  In recent years, opioid overdoses have been on the rise and devastating lives.

 

You may wonder what the point of my story is so far, well I am about to tell you.  I have pledged to do no harm as a pharmacist and help as many people as I can.  Growing up, like most people I was taught to think inside of the box and that most things are black and white not grey.   Given my life experiences of childhood, college, pharmacy school, and working with patients I can tell you bluntly that’s all a lie.  I started to think outside of the box when I began working as a compounding pharmacist.  Compounding pharmacy allows to work outside the confines of big Pharma and the FDA to some extent.  It is here that I learned that hormones and vitamin supplements do play a part in some of our body functions.  Not all illnesses, disorders, and dysfunctions need a big Pharma medication to fix them.

This is where the pursuit of my cannabis knowledge started.

Even though Cannabis has been around and used for over thousands and thousands of years, we actually have very minimal FDA research on this wonderful plant.  However, we do have peer to peer research and personal use benefits documented by a great world wide population.  Cannabis knowledge can be found all over whether it’s in books, the internet, and via speakers on the topic.  Is it all factual? The majority of the information out there is factual, but the rest is based on myths and reefer madness.  There are at least 2 books that I can recommend: Cannabis Pharmacy and The Cannabis Health Index.  After reading these 2 books, I felt to have a better understanding of how cannabis affects the body.  Also,  I learned about the Endocannabinoid System (ECS) which plays an important in our body’s homeostasis.  Unfortunately, the ECS is only lightly touched on in medical school, pharmacy school, and even nursing school.   Hopefully,  as time goes on the healthcare system will realize the potential of Cannabis as a true medicine.

Over the last 3 years,  I have tried to etch my path in the cannabis industry.  I started my journey out as an associate publisher for Sensi Magazine, a lifestyle magazine with a cannabis touch originally based out of Colorado.  I helped to establish the Las Vegas market.  During my time with Sensi, I had the opportunity to network with many leaders in the cannabis industry as well as watch the cannabis scene mature in Las Vegas.   After being immersed in the cannabis scene for quite a while I decided that it was my time to take my cannabis journey to the next level.

In 2018, the USDA passed the farm bill to allow for the further legalization of industrial hemp.  I saw this as opportunity to start my own business in cannabis under this new provision and see where the road took me.  In late 2019, I opened Happy Hemp Pharm.  Happy Hemp Pharm is a small boutique business than prides itself on handcrafted and quality products.

Unfortunately as you all know Covid hit 2020 and slowed all the events down to complete halt.  Luckily, it allowed more time for product development and placement.  However, the only place that didn’t shut down during the pandemic was social media.  You would think with legalization happening throughout the states and parts of the world it would be easy to navigate the social media waters, that is truly not the case. Since cannabis is still federally classified as a class 1 controlled substance Facebook and Instagram are still quite discriminating towards cannabis related posts.

As we are already almost a quarter way done with 2021, I plan to continue to steadily grow and adapt my business to the ever changing cannabis/hemp industry.

Stay tuned to these pages …


EDITOR’S NOTE: Daniel Asarch will be a featured speaker and panelist at the upcoming G4 Live Budtender Awards.